Holly Heights Care and Rehab: Psychotropic Drug Violations - CO
The citation, issued August 21, falls under a category federal regulators place alongside abuse, neglect, and exploitation. That is not a coincidence of bureaucratic filing. Chemical restraint, the practice of using medication to subdue or restrict a person rather than to treat a medical condition, is considered by federal health authorities a form of harm in the same family as physical abuse. The inspectors who cited Holly Heights placed this finding there deliberately.
The deficiency was classified as isolated, meaning inspectors did not find it happening across the entire resident population. But isolated does not mean harmless. The severity level assigned, a D on the federal scale, means there was no documented actual harm at the time of inspection, and also means inspectors concluded there was potential for more than minimal harm. That is the threshold at which federal regulators require a facility to act.
Eleven deficiencies were cited during this inspection. This was one of them.
Holly Heights reported a correction date of September 19, 2025, roughly four weeks after inspectors left the building.
The drug category at the center of the citation, psychotropics, covers a wide range of medications. Antipsychotics. Antidepressants. Anti-anxiety drugs. Sedatives. In a nursing home context, these medications carry particular weight. Older adults metabolize drugs differently than younger patients. The same dose that stabilizes a 40-year-old can leave an 85-year-old sedated, unsteady, and unable to speak clearly or walk without falling. The risks compound: falls, aspiration, cognitive decline, a faster overall deterioration.
When these medications are given without a legitimate clinical reason, without a diagnosis that warrants them, without evidence that less powerful interventions were tried first, or in doses that exceed what a condition requires, they stop being treatment. They become restraint. A person who cannot protest, cannot get up, cannot resist, because they have been chemically quieted, has been restrained as surely as if someone had tied them to a chair.
The inspection report does not name the residents involved. It does not describe what medications were given, in what doses, or for what stated reasons. It does not say whether residents or their families were told about the prescriptions, or whether anyone pushed back. The record is thin in the way that regulatory summaries often are, a conclusion without the full body of evidence that inspectors gathered in the rooms and hallways of the facility over the course of their visit.
What the record does say is that inspectors found it, found it serious enough to cite, and found it falling under the same federal framework that governs how nursing homes treat their most vulnerable residents.
The use of psychotropic medications in nursing homes has been a documented problem in American elder care for decades. Federal efforts to reduce unnecessary antipsychotic use in nursing home residents began in earnest in 2012, when the Centers for Medicare and Medicaid Services launched a national initiative after data showed that roughly 30 percent of nursing home residents were receiving antipsychotic medications, many of them residents with dementia who had no diagnosis that would justify the drugs. The initiative pushed that number down over the following years. But citations like the one at Holly Heights are a reminder that the pressure to use medication as a management tool, rather than a medical intervention, does not disappear because a national campaign says it should.
Dementia is the condition most associated with inappropriate psychotropic prescribing in nursing homes. Residents with dementia may become agitated, may call out repeatedly, may resist care, may pace or wander. These behaviors are distressing for staff and for other residents. They are also symptoms of a disease, not evidence of a psychiatric condition that requires antipsychotic treatment. For years, the response in too many facilities was to medicate the behavior away. The person became quieter. The ward became easier to manage. And the resident, somewhere underneath the sedation, lost more of whatever remained.
The inspection report for Holly Heights does not say whether the residents involved had dementia. It does not say whether the medications were antipsychotics or another class of psychotropic drugs. It does not say whether the prescriptions were new or longstanding, whether they had been reviewed, or whether anyone at the facility had raised a concern before inspectors arrived.
Facilities are required to review psychotropic prescriptions regularly, to document clinical justification, and to attempt dose reductions when appropriate. The citation at Holly Heights suggests that process broke down somewhere, for at least one resident, in a way that inspectors found significant enough to put in writing.
Four weeks passed between the inspection and the facility's reported correction date. That is a short window, and it raises its own questions. Correcting an inappropriate psychotropic prescription is not a simple administrative fix. It requires a physician to review the medication, to determine whether it should be tapered or discontinued, to monitor the resident through that process. Tapering psychotropic medications in elderly patients requires care. Stopping them abruptly can cause withdrawal. Done correctly, it takes time and attention.
Whether the correction Holly Heights reported on September 19 reflected that kind of careful clinical work, or whether it reflected a policy update and a signature on a form, the inspection record does not say.
What the record says is that eleven things were wrong when inspectors arrived at Holly Heights Care and Rehabilitation on August 21, 2025. One of them involved giving residents powerful medications that could limit their ability to function, without sufficient justification for doing so. That finding was placed, by the federal inspectors who made it, in the same category as abuse.
The residents involved remain unnamed. The medications remain unspecified. The clinical decisions that led to the citation, and the people who made them, are not identified in the public record. What is known is that at least one person living at Holly Heights was receiving a psychotropic drug that inspectors concluded they may not have needed, and that the potential for harm from that drug was real enough to require a formal response.
A person living in a nursing home cannot easily advocate for themselves. Many cannot track their own medications. Many do not know what they are being given or why. Many have family members who visit infrequently, who trust that the facility is managing their loved one's care responsibly, who would have no way of knowing that an inspector had walked through the door and found something wrong.
That is the condition under which this citation was made. Not in a facility that was under scrutiny because a family had complained loudly, not because a resident had been visibly harmed, but because inspectors came in and looked, and found what they found, in a facility where eleven things needed correcting.
The correction date has passed. The record shows the facility says it fixed the problem. The residents who were there in August, who were receiving those medications, are still there, or they have moved on, or some of them have died, as residents of nursing homes do. The inspection report does not follow them.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Holly Heights Care and Rehabilitation from 2025-08-21 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: This article is based on inspection data downloaded directly from the Centers for Medicare & Medicaid Services (CMS) via Medicare.gov. CMS releases inspection reports in bulk; we publish the findings as documented by state surveyors in the official Form CMS-2567 Statement of Deficiencies.
Plan of correction: The CMS report we receive does not include the facility's plan of correction. Facilities submit plans of correction separately to state survey agencies and those responses may not be reflected in CMS data at the time of publication. The absence of a plan of correction in our data does not mean one was not filed. Readers who want information about corrective steps taken are encouraged to contact the facility directly or their state survey agency.
Corrections may have occurred: Inspection reports reflect conditions observed on the date of the survey. Facilities may have implemented corrections, staffing changes, additional training, or other remediation since the report was issued. We report what CMS provides and encourage readers to seek current information from the facility.
Editorial process: Inspection findings are extracted from CMS source documents and synthesized using AI, reviewed for factual accuracy against the original report by our editorial team.
Corrections: We strive for accuracy in everything we publish. If you believe any fact in this article is incorrect, please contact us with details, and we will review and correct it promptly.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: November 4, 2026 · Our methodology
HOLLY HEIGHTS CARE AND REHABILITATION in DENVER, CO was cited for violations during a health inspection on August 21, 2025.
The citation, issued August 21, falls under a category federal regulators place alongside abuse, neglect, and exploitation.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.